Peri-Menopausal Health(MPN01)

When women reach the age of 45 to 55, ovarian function gradually changes, and hormone secretion decreases, leading to menopause and a series of physical and emotional changes. This examination program aims to help you clearly understand the stage you are in through objective medical data and assess the long-term health risks associated with menopause.

Key components include:

• Assessment of Menopausal Hormone Levels: By testing key female hormone indices such as follicle-stimulating hormone (FSH) and estradiol (E2), this assessment objectively determines whether the body has entered the menopausal or post-menopausal stage.
• Screening for Osteoporosis Risk: A decrease in estrogen levels is the primary cause of accelerated bone loss. This program evaluates the risk of osteoporosis through DEXA bone density testing, helping to prevent future fractures.
• Assessment of Cardiovascular Health: The risk of cardiovascular diseases increases for menopausal women. By measuring indicators such as lipids, cholesterol, and blood sugar, early management of related risks can be facilitated.

Report written by Radiology Specialist